JP2005200350A - Carbonated foot bath - Google Patents
Carbonated foot bath Download PDFInfo
- Publication number
- JP2005200350A JP2005200350A JP2004008455A JP2004008455A JP2005200350A JP 2005200350 A JP2005200350 A JP 2005200350A JP 2004008455 A JP2004008455 A JP 2004008455A JP 2004008455 A JP2004008455 A JP 2004008455A JP 2005200350 A JP2005200350 A JP 2005200350A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- carbonated
- carbon dioxide
- foot bath
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Devices For Medical Bathing And Washing (AREA)
- Cosmetics (AREA)
Abstract
【課題】足浴を行っている5〜30分の間中温湯中の二酸化炭素濃度が1000mg/L以上に維持出来る炭酸足浴剤を提供すること。
【解決手段】炭酸塩及び/又は炭酸水素塩(A)が20〜60質量%、有機酸(B)が9〜50質量%、吸湿剤(C)が10〜70質量%、融点が40℃以上で且つHLBが2〜10の界面活性剤(D)が0.1〜10質量%である炭酸足浴剤
【選択図】選択図なしAn object of the present invention is to provide a carbonic acid footbath that can maintain the carbon dioxide concentration in hot water during a footbath for 5 to 30 minutes at 1000 mg / L or more.
SOLUTION: Carbonate and / or bicarbonate (A) is 20 to 60% by mass, organic acid (B) is 9 to 50% by mass, hygroscopic agent (C) is 10 to 70% by mass, and melting point is 40 ° C. A carbonated foot bath with a surfactant (D) having an HLB of 2 to 10 in an amount of 0.1 to 10% by mass [Selection] No selection
Description
本発明は、天然炭酸泉と同等の高濃度の溶存二酸化炭素濃度が得られる炭酸足浴剤に関する。 The present invention relates to a carbonated footbath that provides a high concentration of dissolved carbon dioxide equivalent to that of a natural carbonated spring.
足浴は全身浴と異なり、入浴を禁止されている慢性疾患患者や臥床患者に対しても適用でき、また就寝前の足浴は入睡眠を促すことが経験的に知られている。38〜42℃の温浴が一般に用いられ、足浴時間は5〜30分くらいの間で目的に応じて選択される(非特許文献1参照)。
一方、二酸化炭素ガスを溶存させた温浴は、末端血管拡張作用、皮膚血流量増加作用、温感維持作用があり、欧州では古くより高濃度天然炭酸泉が末梢血管障害、高血圧症、心臓病などの治療に用いられてきた。ところで天然炭酸泉は遊離炭酸濃度1000mg/L以上を有するものと規定されているが、一般市販の炭酸入浴剤を用いた炭酸温浴では遊離炭酸濃度(遊離二酸化炭素濃度)が約100mg/Lと天然炭酸泉に比べて低いのが実状である(非特許文献2参照)。
Foot bathing is different from whole body bathing and can be applied to chronically ill patients and bedridden patients who are prohibited from bathing, and it is empirically known that foot bathing before going to bed promotes sleeping. A warm bath of 38 to 42 ° C. is generally used, and the foot bathing time is selected in accordance with the purpose within about 5 to 30 minutes (see Non-Patent Document 1).
On the other hand, warm baths in which carbon dioxide gas is dissolved have terminal vasodilatory action, skin blood flow increase action, and warmth maintenance action. In Europe, high concentration natural carbonated springs have been used for peripheral vascular disorders, hypertension, heart disease, etc. It has been used for treatment. By the way, natural carbonated springs are defined as having a free carbonate concentration of 1000 mg / L or more. However, in a carbonated warm bath using a commercially available carbonated bathing agent, the free carbonate concentration (free carbon dioxide concentration) is about 100 mg / L. The actual situation is lower than (see Non-Patent Document 2).
ここで、炭酸塩化合物、酸性化合物および塩素化イソシアヌル酸化合物を必須成分として配合した足浴剤組成物(以下、従来技術の組成物と呼ぶ)は知られており、効果として末梢循環障害者、閉塞性動脈硬化症患者等の血流不良を持つ者、血流の改善を必要とする者の下肢部の保温、発汗の促進、血流の促進、および皮膚血行の改善、また潰瘍部位や傷口部の感染予防及びケアが行えるだけでなく、連用することにより皮膚症状の軽減あるいは消失を認める等が記載されている(特許文献1参照)。この従来技術の組成物での足浴法の実施においては、溶存炭酸ガス濃度(遊離二酸化炭素濃度)が300〜3000mg/L、好ましくは500〜1500mg/Lであり、且つ遊離塩素濃度が1〜100mg/L、好ましくは10〜50mg/Lであることが記載されている。 Here, a footbath composition containing a carbonate compound, an acidic compound and a chlorinated isocyanuric acid compound as essential components (hereinafter referred to as a composition of the prior art) is known, and its effects are peripheral circulation disorder, obstruction Persons with poor blood flow, such as patients with atherosclerosis, those who need improvement in blood flow, warming the lower limbs, promoting sweating, promoting blood flow, improving skin blood circulation, ulcer sites and wounds In addition to being able to prevent and care for infection, it is described that reduction or disappearance of skin symptoms is observed by continuous use (see Patent Document 1). In the practice of the foot bath method with this prior art composition, the dissolved carbon dioxide concentration (free carbon dioxide concentration) is 300 to 3000 mg / L, preferably 500 to 1500 mg / L, and the free chlorine concentration is 1 to 100 mg. / L, preferably 10 to 50 mg / L.
ところで、末梢循環障害者、閉塞性動脈硬化症患者等の血流不良を持つ者、血流の改善を必要とする者の様な重篤な症状を有する者ではなく、立ち仕事で足がむくむ、冷え性で夜寝つきが悪い等重篤でない症状の者が従来技術の組成物を使って足浴を行った場合、症状が改善されたと十分に実感できるには至っていない。
この原因を精査したところ、症状が重篤ではない者の場合は効果が自覚し難いことに加え、従来技術の組成物は温湯に溶解した直後で遊離二酸化炭素濃度は確かに1500mg/L程度まで達したが5分もすると750mg/L程度まで減少することが分かった。足浴では湯量が5L程度と少なく、また湯の深さも10〜15cmと浅い為に、短時間であれば1000mg/L以上の溶存二酸化炭素濃度の温湯を得ることは出来るが5〜30分と時間が長くなると湯面表面から二酸化炭素が逸散してしまい高濃度の遊離二酸化炭素濃度を維持することは難しい。
By the way, people with poor blood flow, such as those with peripheral circulatory disorders, patients with obstructive arteriosclerosis, and those with serious symptoms such as those who need improvement in blood flow, are swollen by standing work When a person with a non-serious symptom, such as cold sleep and poor sleep, performs a foot bath using a composition of the prior art, it has not been possible to fully realize that the symptom has been improved.
When this cause was investigated, in the case of a person whose symptoms are not severe, the effect is difficult to realize, and the composition of the prior art is immediately dissolved in hot water, and the free carbon dioxide concentration is certainly up to about 1500 mg / L. However, it was found that it decreased to about 750 mg / L in 5 minutes. In the foot bath, the amount of hot water is as small as about 5L, and the depth of the hot water is as shallow as 10-15cm. Therefore, hot water with a dissolved carbon dioxide concentration of 1000mg / L or more can be obtained for a short time, but it takes 5-30 minutes. If the length is long, carbon dioxide escapes from the surface of the hot water surface, and it is difficult to maintain a high concentration of free carbon dioxide.
本発明は、足浴の効果が認知できる様に、足浴を行っている5〜30分の間、温湯中の二酸化炭素濃度を1000mg/L以上に維持出来る炭酸足浴剤を提供することを目的とする。 An object of the present invention is to provide a carbonated foot bath agent capable of maintaining the carbon dioxide concentration in warm water at 1000 mg / L or more for 5 to 30 minutes during which the foot bath is performed so that the effect of the foot bath can be recognized. .
本発明者等は、前記課題を解決する為、(ア)足浴剤を温湯に溶解した時に高濃度の遊離二酸化炭素を発生させる、(イ)発生した二酸化炭素が温湯表面から揮散して遊離二酸化炭素が低下するのを軽減することによって、足浴を行っている5〜30分の間、天然炭酸泉と同様に二酸化炭素濃度が1000mg/L以上の状態を維持できることを見出し、本発明をなすに至った。
すなわち、本発明は炭酸塩及び/又は炭酸水素塩(A)が20〜60質量%、有機酸(B)が9〜50質量%、吸湿剤(C)が10〜70質量%、融点が40℃以上で且つHLBが2〜10の界面活性剤(D)が0.1〜10質量%である炭酸足浴剤である。
In order to solve the above-mentioned problems, the present inventors have (a) generating a high concentration of free carbon dioxide when the footbath is dissolved in hot water. By reducing the decrease in carbon, it was found that the carbon dioxide concentration can be maintained at 1000 mg / L or more in the same manner as natural carbonated spring for 5 to 30 minutes during foot bathing, and the present invention has been made. It was.
That is, in the present invention, the carbonate and / or bicarbonate (A) is 20 to 60% by mass, the organic acid (B) is 9 to 50% by mass, the hygroscopic agent (C) is 10 to 70% by mass, and the melting point is 40. It is a carbonated foot bath agent in which the surfactant (D) having a temperature of not lower than ° C. and an HLB of 2 to 10 is 0.1 to 10% by mass.
本発明は、5Lと少ない温湯で行う足浴でも足浴を行っている5〜30分の間、温湯中の遊離二酸化炭素濃度を1000mg/L以上に維持出来る効果を有し、立ち仕事で足がむくむや冷え性で夜寝つきが悪い等重篤でない症状の者でも足浴の効果が期待できる。 The present invention has the effect of maintaining the free carbon dioxide concentration in hot water at 1000 mg / L or more for 5 to 30 minutes even when foot bathing is performed with a small amount of hot water as low as 5 L, and the foot is swollen by standing work. The effect of foot bathing can be expected even for those with non-serious symptoms such as poor coldness and poor sleep.
以下、本発明について詳細に説明する。
本発明は、(ア)足浴剤を温湯に溶解した時に高濃度の遊離二酸化炭素を発生させる、(イ)発生した二酸化炭素が温湯表面から揮散して遊離二酸化炭素が低下するのを軽減することによって課題を解決した。
上記(ア)については、遊離二酸化炭素を発生させる成分である炭酸水素塩(A)及び有機酸(B)の含有量を多くすることが重要であることは容易に推察できるところである。
また前記の通り、遊離二酸化炭素は(A)と(B)との反応によって発生するので、(A)と(B)との比率を考慮した方が好ましく、理論的には、(A)が1モルに対して(B)が1モル存在する場合が最も効率よく遊離二酸化炭素を発生させることが出来るが、温湯に溶解した成分全てが反応に供することは無くまた原料には不純物が混ざっているので、あくまで目安であることも容易に推察できるところである。
Hereinafter, the present invention will be described in detail.
The present invention (a) generates a high concentration of free carbon dioxide when the footbath is dissolved in warm water, (b) reduces the carbon dioxide generated by volatilization of the generated carbon dioxide from the hot water surface Solved the problem.
Regarding (a) above, it can be easily inferred that it is important to increase the contents of the bicarbonate (A) and the organic acid (B), which are components that generate free carbon dioxide.
As described above, since free carbon dioxide is generated by the reaction of (A) and (B), it is preferable to consider the ratio of (A) to (B). Theoretically, (A) is When one mole of (B) is present per mole, free carbon dioxide can be generated most efficiently, but not all the components dissolved in hot water are used for the reaction, and impurities are mixed in the raw material. Therefore, it can be easily guessed that it is only a guide.
ところが、(A)及び(B)だけでは、足浴剤製造時、保管時、輸送時に空気中の水分により二酸化炭素が発生してしまい、足浴を行っている5〜30分の間1000mg/L以上の高濃度の遊離二酸化炭素を維持できるほどの二酸化炭素を温湯中に有効に溶け込ませることができないことが分かった。
そこで本発明では、(A)、(B)に加え第3成分として吸湿剤(C)が含有されていることによって(ア)を解決した。
また上記(イ)については、融点が40℃以上で且つHLBが2〜10の界面活性剤(D)で構成される泡によって温湯表面を覆うことによって、二酸化炭素が温湯表面から揮散するのを軽減させることによって解決した。
However, in (A) and (B) alone, carbon dioxide is generated by moisture in the air during foot bath preparation production, storage, and transportation, and 1000 mg / L or more for 5 to 30 minutes during foot bathing. It was found that carbon dioxide that can maintain a high concentration of free carbon dioxide cannot be effectively dissolved in hot water.
Therefore, in the present invention, (A) is solved by including the hygroscopic agent (C) as the third component in addition to (A) and (B).
Regarding (i) above, carbon dioxide is volatilized from the hot water surface by covering the hot water surface with foam composed of a surfactant (D) having a melting point of 40 ° C. or higher and an HLB of 2 to 10. Solved by mitigating.
以下、各成分について詳述する。
先ず炭酸塩及び/又は炭酸水素塩(A)は有機酸(B)により遊離二酸化炭素を発生させる成分であり、該濃度を1000mg/L以上にする為には、(A)は20〜60質量%であることが必要である。好ましくは、25〜50質量%である。
(A)の具体例としては、炭酸ナトリウム、炭酸水素ナトリウム、セスキ炭酸ナトリウム(ニ炭酸水素三ナトリウム)、炭酸カリウム、炭酸水素カリウム、炭酸アンモニウム等及びこれ等の混合物が挙げられる。好ましくは、温湯中に溶解してもpHがあまりアルカリ性にならない炭酸水素ナトリウムを主体成分とし少なくとも25質量%配合した場合である。(A)に炭酸水素ナトリウムのみを利用した場合には、温湯量が5Lであれば足浴剤中に(A)が10g程度以上含有すれば遊離二酸化炭素濃度は1000mg/L以上となる。
Hereinafter, each component will be described in detail.
First, the carbonate and / or bicarbonate (A) is a component that generates free carbon dioxide with the organic acid (B), and in order to increase the concentration to 1000 mg / L or more, (A) is 20 to 60 mass. %. Preferably, it is 25-50 mass%.
Specific examples of (A) include sodium carbonate, sodium bicarbonate, sodium sesquicarbonate (trisodium dicarbonate), potassium carbonate, potassium bicarbonate, ammonium carbonate, and the like, and mixtures thereof. Preferably, sodium bicarbonate whose pH is not so alkaline even when dissolved in warm water is blended with at least 25% by mass as a main component. When only sodium hydrogen carbonate is used for (A), if the amount of hot water is 5 L, the concentration of free carbon dioxide will be 1000 mg / L or more if (A) is contained in about 10 g or more in the foot bath.
更に好ましくは、これに前記成分が空気中の湿気により分解しても、分解により発生した二酸化炭素を吸収して炭酸水素ナトリウムに変化する炭酸ナトリウムを足浴剤全体量のうち1〜15質量%程度共存させる場合である。但し炭酸ナトリウムが15質量%より多くなると、下記有機酸(B)配合量にもよるが、温湯のpHが6.5以上になる傾向にあり、この状態では二酸化炭素はCO3 2−イオン或いはHCO3 −の状態で存在し、末端血管拡張作用、皮膚血流量増加作用、温感維持作用等を発揮する遊離二酸化炭素での存在割合が減少する傾向にある。
次に有機酸(B)は、(A)と反応して遊離二酸化炭素を発生させると共に温浴を弱酸性(pH=5.0〜6.5)に保つことによって遊離二酸化炭素濃度を維持する役割がある。この効果を発揮させるために(B)は9〜50質量%必要である。好ましくは、25〜50質量%である。
More preferably, even if the above components are decomposed by moisture in the air, sodium carbonate that absorbs carbon dioxide generated by the decomposition and changes into sodium hydrogen carbonate is about 1 to 15% by mass of the total amount of the foot bath. This is the case of coexistence. However, when the amount of sodium carbonate exceeds 15% by mass, although depending on the blending amount of the organic acid (B) described below, the pH of the hot water tends to be 6.5 or more. In this state, carbon dioxide is CO 3 2- ion or It exists in the state of HCO 3 − , and the proportion of free carbon dioxide that exhibits terminal vasodilatory action, skin blood flow increase action, warmth maintenance action, etc. tends to decrease.
Next, the organic acid (B) reacts with (A) to generate free carbon dioxide and to maintain the free carbon dioxide concentration by keeping the warm bath weakly acidic (pH = 5.0 to 6.5). There is. In order to exhibit this effect, (B) needs 9-50 mass%. Preferably, it is 25-50 mass%.
(B)の具体例としては、コハク酸、酢酸、シュウ酸、グルタル酸、酒石酸、クエン酸、フタル酸、フマル酸、リンゴ酸、アジピン酸及びこれ等の塩等が挙げられる。また前記化合物の混合物であっても良い。
更に吸湿剤(C)は、本発明の炭酸足浴剤を保存している間に空気中の湿気により(A)が分解して二酸化炭素を放出するのを防止する役割がある。特に本発明の炭酸足浴剤は、温浴中の溶存二酸化炭素濃度が1000mg/L以上と高濃度にする為に吸湿性の高い(A)及び(B)の含有量が高く、本発明の炭酸足浴剤を2年程度保存しても所望の性能を発揮させる為には吸湿剤(C)は10〜70質量%必要である。好ましくは、20〜60質量%である。
Specific examples of (B) include succinic acid, acetic acid, oxalic acid, glutaric acid, tartaric acid, citric acid, phthalic acid, fumaric acid, malic acid, adipic acid, and salts thereof. Moreover, the mixture of the said compound may be sufficient.
Further, the hygroscopic agent (C) has a role of preventing (A) from being decomposed and releasing carbon dioxide by moisture in the air while the carbonated foot bath of the present invention is stored. In particular, the carbonated foot bath of the present invention has a high hygroscopic content of (A) and (B) in order to make the dissolved carbon dioxide concentration in the warm bath as high as 1000 mg / L or more. In order to exhibit the desired performance even if the agent is stored for about 2 years, the hygroscopic agent (C) needs to be 10 to 70% by mass. Preferably, it is 20-60 mass%.
(C)の具体例としては、無水硫酸アルミニウム、無水塩化カルシウム、無水塩化コバルト、無水硫酸マグネシウム、無水塩化ニッケル、無水炭酸ナトリウム、無水ピロリン酸二水素ナトリウム、無水リン酸二ナトリウム、無水メタ珪酸ナトリウム、無水硫酸ナトリウム、無水亜硫酸ナトリウム、無水四硼酸ナトリウム、無水チオ硫酸ナトリウム、無水硫酸亜鉛等、無水和物で存在出来て且つ多量の水を結晶構造の中に取り込める無機塩、活性炭、シリカゲル、高分子吸収体等が挙げられる。また前記化合物の混合物であっても良い。
また、界面活性剤(D)は、温湯表面を泡で覆って二酸化炭素の揮散を軽減させる為には、融点が40℃以上で且つHLBが2〜8である必要がある。ここで言うHLB(Hydrophilic−Lipophilic Balance)とは、化合物の親水性と疎水性の度合いを示す指標であり、値が高いほど親水性が強いことを示している。(改定二版、油脂化学便覧、1982年、丸善、710頁参照)界面活性剤(D)の含有量は0.1〜10質量%である必要がある。好ましくは、0.5〜5.0質量%である。
Specific examples of (C) include anhydrous aluminum sulfate, anhydrous calcium chloride, anhydrous cobalt chloride, anhydrous magnesium sulfate, anhydrous nickel chloride, anhydrous sodium carbonate, anhydrous sodium dihydrogen pyrophosphate, anhydrous disodium phosphate, and anhydrous sodium metasilicate. , Anhydrous sodium sulfate, anhydrous sodium sulfite, anhydrous sodium tetraborate, anhydrous sodium thiosulfate, anhydrous zinc sulfate, etc., which can be present in anhydrous products and can incorporate a large amount of water into the crystal structure, activated carbon, silica gel, high Examples include molecular absorbers. Moreover, the mixture of the said compound may be sufficient.
Further, the surfactant (D) needs to have a melting point of 40 ° C. or higher and HLB of 2 to 8 in order to reduce the volatilization of carbon dioxide by covering the hot water surface with foam. Here, HLB (Hydrophilic-Lipophilic Balance) is an index indicating the degree of hydrophilicity and hydrophobicity of a compound. The higher the value, the stronger the hydrophilicity. (Refer to the 2nd revised edition, oleochemicals manual, 1982, Maruzen, page 710) The content of the surfactant (D) needs to be 0.1 to 10% by mass. Preferably, it is 0.5-5.0 mass%.
(D)の融点が40℃未満では、本発明の炭酸足浴剤を保存又は輸送中に融解してしまい製品性能を著しく阻害する。
(D)のHLBが2未満では湯面上に均一な泡の膜が形成できない。またHLBが10を超えると、(C)が含有されていても足浴剤を製造、保管、輸送中に吸湿して(A)の分解を促進してしまう。また、錠剤に成形する場合には型からの剥離性に劣る。
(D)の含有量が0.1質量%未満では泡の発生量が不十分であり、10質量%より多い場合は(C)が含有されていても足浴剤を製造、保管、輸送中に吸湿して(A)の分解を促進してしまう。
When the melting point of (D) is less than 40 ° C., the carbonated foot bath of the present invention is melted during storage or transportation, and the product performance is significantly impaired.
If the HLB of (D) is less than 2, a uniform foam film cannot be formed on the molten metal surface. On the other hand, if the HLB exceeds 10, even if (C) is contained, the foot bath agent is absorbed during production, storage and transportation, and the decomposition of (A) is promoted. Moreover, when shape | molding into a tablet, it is inferior to the peelability from a type | mold.
When the content of (D) is less than 0.1% by mass, the amount of foam generated is insufficient. When the content is more than 10% by mass, the footbath is produced, stored and transported even if (C) is contained. It absorbs moisture and promotes decomposition of (A).
(D)の具体例としては、グリセリンモノステアレート、ジグリセリンジステアレート等のグリセリン脂肪酸エスエル、ソルビタンパルミテート、ソルビタンステアレート等のソルビタン脂肪酸エステル、ポリオキシエチレン(5)グリセリンステアレート、ポリオキシエチレン(2)グリセリンステアレート等のポリオキシエチレン脂肪酸エステル、ショ糖硬化牛脂エステル、ショ糖ステアリン酸エステル等のショ糖脂肪酸エステル等が挙げられる。好ましくは、微粉体で且つ含水率の低いものがよく、その具体例としては第一工業製薬社製ショ糖脂肪酸エステルF−20、F−50、F−70、F−90(いずれも商品名)が挙げられる。 Specific examples of (D) include glycerol fatty acid esters such as glycerol monostearate and diglycerol distearate, sorbitan fatty acid esters such as sorbitan palmitate and sorbitan stearate, polyoxyethylene (5) glycerol stearate, polyoxy Examples thereof include polyoxyethylene fatty acid esters such as ethylene (2) glyceryl stearate, sucrose fatty acid esters such as sucrose-cured tallow ester, and sucrose stearate. Preferably, it is fine powder and has a low water content, and specific examples thereof include sucrose fatty acid esters F-20, F-50, F-70, F-90 (all trade names) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. ).
また好ましくは、本発明の炭酸足浴剤中に殺菌剤を本発明の炭酸足浴剤の性能を阻害しない範囲で含有しても良い。
殺菌剤の具体例としては、ジクロロイソシアヌール酸及びその塩、トリクロロイソシアヌール酸及びその塩、次亜塩素酸塩等の塩素化合物、ヨウ化カリウム等のヨウ素化合物、イソプロピルメチルフェノール、レゾルシン、ヒノキチオール、パラクロロメタクレゾール、トリクロサン等のフェノール系殺菌剤、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、塩化クロルヘキシジン、グルコン酸クロルヘキシジン等のカチオン系殺菌剤、カテキン、ワサビ抽出物、キトサン等の天然物由来の化合物が挙げられる。
Preferably, a bactericidal agent may be contained in the carbonated footbath of the present invention as long as the performance of the carbonated footbath of the present invention is not impaired.
Specific examples of the disinfectant include dichloroisocyanuric acid and salts thereof, trichloroisocyanuric acid and salts thereof, chlorine compounds such as hypochlorite, iodine compounds such as potassium iodide, isopropylmethylphenol, resorcin, hinokitiol, Derived from phenolic fungicides such as parachlorometacresol and triclosan, cationic bactericides such as benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, chlorhexidine chloride, chlorhexidine gluconate, catechins, horseradish extract, chitosan and other natural products The compound of this is mentioned.
更に、鉱泉に含まれる成分、保湿剤、生薬、精油、アミノ酸類、蛋白質分解酵素や脂肪分解酵素等の酵素、ビタミンC、ビタミンE等のビタミン剤、足浴剤を顆粒や錠剤に成形する際に用いられる附型剤や滑沢剤、並びに顔料、香料、発泡剤、油類等を本発明の炭酸足浴剤の性能を阻害しない範囲で含有しても良い。
鉱泉に含まれる成分の具体的な例としては、塩化ナトリウム、塩化アンモニウム、フッ化物、硼砂、硼酸及びその化合物、無水珪酸及びその塩、メタ珪酸及びその塩、リン酸ナトリウム、ポリリン酸ナトリウム、リン酸水素カルシウム、イオウ化合物等が挙げられる。
Furthermore, when molding ingredients, moisturizers, herbal medicines, essential oils, amino acids, enzymes such as proteolytic enzymes and lipolytic enzymes, vitamins such as vitamin C and vitamin E, and foot baths contained in mineral springs into granules and tablets The emulsifying agent and lubricant used, as well as pigments, fragrances, foaming agents, oils, and the like may be contained within a range that does not impair the performance of the carbonated foot bath of the present invention.
Specific examples of components contained in the mineral spring include sodium chloride, ammonium chloride, fluoride, borax, boric acid and its compounds, anhydrous silicic acid and its salts, metasilicic acid and its salts, sodium phosphate, sodium polyphosphate, phosphorus Examples include calcium oxyhydrogen and sulfur compounds.
保湿剤の具体例としては、グリセリン、ポリエチレングリコール、ソルビトール、ポリビニルアルコール、ポリビニルピロリドン、ヌカ油、コラーゲン、ラノリン、ヒアルロン酸、乳酸及びその塩、グルタミン酸及びその塩、藻類等が挙げられる。
生薬の具体的な例としては、トウヒ、ショウブ、アロエ、オオバク、ヨモギ、桃の葉エキス、トウキ等が挙げられる。
精油の具体的な例としては、ローズマリー、カモミール、レモン、レモングラス、タイム、ラベンダー、ジャスミン、リモネン、ユーカリ油、ミント類等が挙げられる。
アミノ酸類の具体的な例としては、グリシン、ロイシン、アスパラギン酸、グルタミン酸等が挙げられる。
Specific examples of the humectant include glycerin, polyethylene glycol, sorbitol, polyvinyl alcohol, polyvinyl pyrrolidone, nuka oil, collagen, lanolin, hyaluronic acid, lactic acid and its salt, glutamic acid and its salt, and algae.
Specific examples of herbal medicines include spruce, shobu, aloe, oat, mugwort, peach leaf extract, and toki.
Specific examples of essential oils include rosemary, chamomile, lemon, lemongrass, thyme, lavender, jasmine, limonene, eucalyptus oil, mint and the like.
Specific examples of amino acids include glycine, leucine, aspartic acid, glutamic acid and the like.
いずれも医薬部外品、化粧品の原料として認められているものが好ましい。
本発明の炭酸足浴剤の形態は、微粉体、顆粒、錠剤等温湯に溶かすことができる形態であれば良く、好ましくは粉が舞わない等の理由から顆粒または錠剤である。
また本発明の炭酸足浴剤の量は、足浴剤が上記(A)、(B)、(C)、(D)及び殺菌剤、香料のみで構成されている場合、温湯量が5Lであれば30〜50g程度が目安となる。
また本発明の炭酸足浴剤を用いて足浴を行う場合、温湯の温度は35〜42℃程度で行うのが一般的である。健康者では35℃でも遊離二酸化炭素の効果により末端血管拡張作用、皮膚血流量増加作用は確認されたが、38℃以下の温度では温感維持作用が実感されにくいので、40℃程度に温度を維持することが好ましい。また本発明の炭酸足浴剤を用いて足浴を行う場合、くるぶし当たりまで温湯に漬かっていることが好ましい。
In any case, those recognized as raw materials for quasi drugs and cosmetics are preferred.
The form of the carbonated foot bath of the present invention may be any form that can be dissolved in warm water such as fine powder, granules, and tablets, and is preferably a granule or tablet for reasons such as powder not dancing.
Moreover, the amount of the carbonated foot bath of the present invention is such that when the foot bath is composed only of the above (A), (B), (C), (D), the disinfectant and the fragrance, the amount of hot water is 5L. About 30-50g becomes a standard.
Moreover, when performing a foot bath using the carbonated foot bath agent of this invention, it is common to perform the temperature of warm water at about 35-42 degreeC. In healthy volunteers, the effects of free blood carbon dioxide on terminal vasodilation and skin blood flow increase were confirmed even at 35 ° C. However, it is difficult to feel warmth at 38 ° C or lower. It is preferable to maintain. Moreover, when performing a foot bath using the carbonated foot bath agent of this invention, it is preferable to be immersed in warm water to the ankle.
足浴の為に、保温(断熱)又は温度制御が出来る足浴器を用いることが好ましく、そのサイズは両足が入る開口部を有し且つくるぶし当たりまで温湯に漬かることができ、更に本発明の炭酸足浴剤は温湯表面に泡の膜が出来るので泡が容器から溢れ出さない深さを有していることが好ましい。例えば、開口部の形状が円形であれば直径が25〜30cmで深さが15〜20cm程度である。 For the foot bath, it is preferable to use a foot bath capable of keeping heat (insulating) or controlling the temperature, and the size of the foot bath has an opening into which both feet can enter and can be immersed in warm water until the ankle comes. Since the agent forms a foam film on the hot water surface, it is preferable that the agent has a depth that prevents the foam from overflowing from the container. For example, if the shape of the opening is circular, the diameter is 25 to 30 cm and the depth is about 15 to 20 cm.
本発明について、以下具体的に説明する。
先ず、以下に用いた評価方法をまとめて記す。
(1)遊離二酸化炭素濃度[CO2(mg/L)]
直径25cm、深さ15cmの円筒形フットバスに40℃の温湯を5L入れ、炭酸足浴剤を該温湯に投入して足湯を作成した。炭酸足浴剤を投入した直後から5分毎に足湯中の遊離二酸化炭素を測定した。
尚、遊離二酸化炭素濃度は、環境省自然環境局、鉱泉分析法指針(平成14年4月)の7−30二酸化炭素、炭酸水素イオンおよび炭酸イオンの定量、(2)遊離二酸化炭素の容量法(68頁)に準拠して測定した。まとめの表中の時間は炭酸足浴剤を温湯投入後の経時時間である。
The present invention will be specifically described below.
First, the evaluation methods used below are summarized.
(1) Free carbon dioxide concentration [CO 2 (mg / L)]
5 L of hot water at 40 ° C. was placed in a cylindrical foot bath having a diameter of 25 cm and a depth of 15 cm, and a foot bath was prepared by adding a carbonated foot bath to the hot water. Free carbon dioxide in the footbath was measured every 5 minutes immediately after the carbonated foot bath was added.
In addition, free carbon dioxide concentration is 7-30 carbon dioxide, hydrogen carbonate ion and carbonate ion quantification of Ministry of the Environment natural environment station, mineral spring analysis method guideline (April, 2002), (2) capacity method of free carbon dioxide (Page 68). The time in the summary table is the elapsed time after the carbonated foot bath was added.
(2)実用評価
30歳前後で毎日立ち仕事をしていて足のむくみがきになる女性30名に15分間、3日間足浴を行って貰い感想を聞きた。評価は、足のむくみが軽減したと答えた人の割合が85%以上の場合を「◎」、70%以上85%未満の場合を「○」、50%以上70%未満の場合を「△」、50%未満を「×」とした。
本発明を実施例に基づいて説明する。
(2) Practical evaluation We asked 30 women who were standing and working everyday around the age of 30 to have a swollen foot for 15 minutes for 3 days and heard their ugly impressions. The evaluation is “◎” when the proportion of people who answered that the swelling of the foot has been reduced is 85% or more, “◯” when the proportion is 70% or more and less than 85%, and “△” when the proportion is 50% or more and less than 70%. ", Less than 50% was taken as" x ".
The present invention will be described based on examples.
[実施例1]
炭酸塩及び/又は炭酸水素塩(A)として炭酸水素ナトリウムを29.4質量%、有機酸(B)としてコハク酸を29.4質量%、吸湿剤(C)として無水硫酸ナトリムを39.2質量%、融点が40℃以上で且つHLBが2〜10の界面活性剤(D)として第一工業製薬社製DKエステルS−50(商品名)(融点:63℃、HLB:6)を2質量%、それぞれ計量後混合して白色粉体の混合物を得た。この混合物を35g毎にニ軸延伸ポリプロピレンフィルム/ポリプロピレンキャスティングフィルム=40μm/30μmの積層フィルム製袋(以下、ポリプロピレン製袋と略す)に封入して炭酸足浴剤の包装体を作成した(サンプルNo.1)。封入したものを40℃、70%RHの恒温恒湿槽に3ヶ月放置した。
放置後、内容物について上記評価方法に従って評価した。評価結果を表1に示す。
[Example 1]
29.4% by weight of sodium hydrogen carbonate as the carbonate and / or bicarbonate (A), 29.4% by weight of succinic acid as the organic acid (B), and 39.2% anhydrous sodium sulfate as the moisture absorbent (C) 2% DK ESTER S-50 (trade name) (melting point: 63 ° C., HLB: 6) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. as a surfactant (D) having a mass%, melting point of 40 ° C. or higher and HLB of 2 to 10 Mass%, each weighed and mixed to obtain a white powder mixture. This mixture was sealed every 35 g in a biaxially stretched polypropylene film / polypropylene casting film = 40 μm / 30 μm laminated film bag (hereinafter abbreviated as a polypropylene bag) to prepare a carbonated foot bath package (Sample No. 1). 1). The sealed product was left in a constant temperature and humidity chamber at 40 ° C. and 70% RH for 3 months.
After leaving, the contents were evaluated according to the above evaluation method. The evaluation results are shown in Table 1.
[比較例1]
実施例1の内、(D)として第一工業製薬社製DKエステルS−50を配合しなかった以外は、実施例1と同様な評価を繰り返した(サンプルNo.2)。評価結果を表1に示す。
[Comparative Example 1]
In Example 1, the same evaluation as Example 1 was repeated except that DK ester S-50 manufactured by Daiichi Kogyo Seiyaku Co., Ltd. was not blended as (D) (Sample No. 2). The evaluation results are shown in Table 1.
表1において、本発明の炭酸足浴剤(実施例1)では、温湯に投入直後から足湯中の遊離二酸化炭素濃度が1000mg/L以上を維持しており、実用評価でも93%(28名)の評価者が足のむくみ改善を実感できた。
一方、(比較例1)の炭酸足浴剤では、温湯に投入直後では遊離二酸化炭素濃度が1500mg/Lと本発明の炭酸足浴剤と同様1000mg/L以上であったが、5分後には740mg/Lと1000mg/Lを大幅に下回った。また実用評価においても20%(6名)の評価者しか効果を実感出来ていなかった。
In Table 1, in the carbonated footbath of the present invention (Example 1), the free carbon dioxide concentration in the footbath is maintained at 1000 mg / L or more immediately after being added to the hot water, and 93% (28 persons) in practical evaluation. The evaluator was able to feel improvement in swelling of the feet.
On the other hand, in the carbonated footbath of (Comparative Example 1), the concentration of free carbon dioxide was 1500 mg / L as soon as it was added to warm water, which was 1000 mg / L or more like the carbonated footbath of the present invention, but after 750 mg / L after 5 minutes. L and significantly below 1000 mg / L. In practical evaluation, only 20% (6 persons) of evaluators could realize the effect.
[実施例2]
実施例1において、(D)として配合した第一工業製薬社製DKエステルS−50(商品名)の替わりに、HLBが2の第一工業製薬社製DKエステルF−20W(商品名)(融点:65度、HLB:2)及びHLBが9.5のF−90(商品名)(融点:59℃、HLB:9.5)を使用した以外は、実施例1と同様な操作を繰り返した(それぞれサンプルNo.3、No.4)。評価結果を表2に示す。
[Example 2]
In Example 1, instead of DK ester S-50 (trade name) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. blended as (D), DK ester F-20W (trade name) manufactured by Daiichi Kogyo Seiyaku Co., Ltd., with HLB of 2 The same operation as in Example 1 was repeated except that F-90 (trade name) (melting point: 59 ° C., HLB: 9.5) having a melting point of 65 degrees, HLB: 2) and an HLB of 9.5 was used. (Sample No. 3 and No. 4 respectively). The evaluation results are shown in Table 2.
[比較例2]
実施例1において、(D)として配合した第一工業製薬社製DKエステルS−50(商品名)の替わりに、HLBが1の第一工業製薬社製DKエステルF−10(商品名)(融点:65℃、HLB:1)及びHLBが11のF−110(商品名)(融点:59℃、HLB:11)を使用した以外は、実施例1と同様な操作を繰り返した(それぞれサンプルNo.5、No.6)。評価結果を表2に示す。
[Comparative Example 2]
In Example 1, instead of DK ester S-50 (trade name) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. blended as (D), DK ester F-10 (trade name) manufactured by Daiichi Kogyo Seiyaku Co., Ltd., with HLB of 1 ( The same operation as in Example 1 was repeated except that F-110 (trade name) (melting point: 59 ° C., HLB: 11) having an HLB of 11 and a melting point of 65 ° C., HLB: 1 was used (samples respectively). No. 5, No. 6). The evaluation results are shown in Table 2.
表2において、HLBが2〜10である界面活性剤を使用した本発明の炭酸足浴剤であるサンプルNo.3及びNo.4は、遊離二酸化炭素濃度が1000mg/L以上を維持しており、実用評価でも共に93%の者が効果を実感していた。
ところが、HLBが1の界面活性剤を使用したサンプルNo.5、HLBが11の界面活性剤を使用したサンプルNo.6は、いずれも遊離二酸化炭素濃度が1000mg/L未満となり、実用評価においてもサンプルNo.5が27%、サンプルNo.6では53%といずれも本発明の炭酸足浴剤に比べ劣っていた。
In Table 2, sample No. which is a carbonated footbath of the present invention using a surfactant having an HLB of 2 to 10. 3 and no. In No. 4, the free carbon dioxide concentration was maintained at 1000 mg / L or more, and 93% of the people in both practical evaluations realized the effect.
However, sample No. 1 using a surfactant having an HLB of 1 was used. 5. Sample No. using a surfactant having an HLB of 11 No. 6 has a free carbon dioxide concentration of less than 1000 mg / L. 5 is 27%, sample no. 6 was 53%, both inferior to the carbonated foot bath of the present invention.
[実施例3]
(A)として炭酸水素ナトリウムを29.4質量%、(B)としてコハク酸を29.4質量%、(C)として無水硫酸ナトリムを41.1質量%、(D)として第一工業製薬社製DKエステルS−50(商品名)を0.1質量%、それぞれ計量後混合して白色粉体の混合物を得た。その後、この混合物を打錠機にて直径38mm×厚み18mm、重量35gに成形し、ポリプロピレン製袋に封入して炭酸足浴剤の包装体を作成した(サンプルNo.7)。
また(A)として炭酸水素ナトリウムを29.4質量%、(B)としてコハク酸を29.4質量%、(C)として無水硫酸ナトリムを31.2質量%、(D)として第一工業製薬社製DKエステルS−50(商品名)を10.0質量%、それぞれ計量後混合して白色粉体の混合物を得た後、打錠機にて直径38mm×厚み18mm、重量35gに成形し、ポリプロピレン製袋に封入して炭酸足浴剤を作成した(サンプルNo.8)。
封入したものを40℃、70%RHの恒温恒湿槽に3ヶ月放置した後、内容物について上記評価法に従い評価した。
[Example 3]
(A) 29.4% by mass of sodium bicarbonate, (B) 29.4% by mass of succinic acid, (C) 41.1% by mass of anhydrous sodium sulfate, (D) Daiichi Kogyo Seiyaku Co., Ltd. DK ester S-50 (trade name) manufactured was 0.1% by mass, and each was mixed after weighing to obtain a white powder mixture. Thereafter, this mixture was formed into a diameter of 38 mm × thickness of 18 mm and a weight of 35 g using a tableting machine, and sealed in a polypropylene bag to prepare a package of carbonated foot bath agent (Sample No. 7).
In addition, (A) is 29.4% by mass of sodium bicarbonate, (B) is 29.4% by mass of succinic acid, (C) is 31.2% by mass of anhydrous sodium sulfate, and (D) is Daiichi Kogyo Seiyaku. DK ESTER S-50 (trade name) manufactured by the company was weighed and mixed to obtain a white powder mixture, and then molded into a diameter of 38 mm x thickness of 18 mm and a weight of 35 g using a tableting machine. A carbonated foot bath agent was prepared by enclosing in a polypropylene bag (Sample No. 8).
The sealed product was left in a constant temperature and humidity chamber at 40 ° C. and 70% RH for 3 months, and then the contents were evaluated according to the above evaluation method.
[比較例3]
(A)として炭酸水素ナトリウムを30.0質量%、(B)としてコハク酸を30.0質量%、(C)として無水硫酸ナトリムを40.0質量%、それぞれ計量後混合して白色粉体の混合物を得た後、打錠機にて直径38mm×厚み18mm、重量35gに成形し、ポリプロピレン製袋に封入して炭酸足浴剤の包装体を作成した(サンプルNo.9)。
また(A)として炭酸水素ナトリウムを29.4質量%、(B)としてコハク酸を29.4質量%、(C)として無水硫酸ナトリムを21.2質量%、(D)として第一工業製薬社製DKエステルS−50(商品名)を20.0質量%、それぞれ計量後混合して白色粉体の混合物を得た後、打錠機にて直径38mm×厚み18mm、重量35gに成形し、ポリプロピレン製袋に封入して炭酸足浴剤の包装体を作成した(サンプルNo.10)。
封入したものを40℃、70%RHの恒温恒湿槽に3ヶ月放置した後、内容物について上記評価法に従い評価した。
[Comparative Example 3]
(A) 30.0 mass% sodium bicarbonate as (A), 30.0 mass% succinic acid as (B), 40.0 mass% anhydrous sodium sulfate as (C) Then, the mixture was molded into a diameter of 38 mm × thickness of 18 mm and a weight of 35 g using a tableting machine, and sealed in a polypropylene bag to prepare a package of a carbonated foot bath agent (Sample No. 9).
(A) 29.4% by mass of sodium bicarbonate, (B) 29.4% by mass of succinic acid, (C) 21.2% by mass of anhydrous sodium sulfate, and (D) Daiichi Kogyo Seiyaku DK Ester S-50 (trade name) manufactured by the company was weighed and mixed to obtain a white powder mixture, and then molded into a diameter of 38 mm x thickness of 18 mm and a weight of 35 g using a tableting machine. Then, it was enclosed in a polypropylene bag to produce a package of carbonated foot bath agent (Sample No. 10).
The sealed product was left in a constant temperature and humidity chamber at 40 ° C. and 70% RH for 3 months, and then the contents were evaluated according to the above evaluation method.
表3において、(D)の含有量が0.1〜10質量%の範囲にある本発明の炭酸足浴剤であるサンプルNo.7及びNo.8は、遊離二酸化炭素濃度が1000mg/L以上を維持しており、実用評価でもサンプルNo.7が97%、サンプルNo.8では93%の者が効果を実感していた。
ところが、(D)を含有しないサンプルNo.9、同含有量が20質量%のサンプルNo.10はいずれも遊離二酸化炭素濃度が1000mg/L未満となり、実用評価においてもサンプルNo.9が40%、サンプルNo.10では47%といずれも本発明の炭酸足浴剤に比べ劣っていた。
尚、粉体に比べ錠剤化することによって取扱いが容易になると共に、泡がよりクリーミーになり使用感が粉体よりも優れるとの意見が多かった。
In Table 3, sample No. which is the carbonated foot bath of the present invention having a content of (D) in the range of 0.1 to 10% by mass. 7 and no. No. 8 maintains a free carbon dioxide concentration of 1000 mg / L or more. 7 is 97%, sample no. In 8, 93% of people felt the effect.
However, sample No. containing no (D). 9, Sample No. having the same content of 20% by mass. No. 10 has a free carbon dioxide concentration of less than 1000 mg / L. 9 is 40%, sample no. 10 was 47%, both inferior to the carbonated foot bath of the present invention.
There were many opinions that tableting compared to powder facilitated handling and that the foam became creamy and the usability was superior to that of powder.
[実施例4]
(A)として炭酸水素ナトリウムを29.4質量%、(B)としてコハク酸を29.4質量%、(C)として無水硫酸ナトリムを39.1質量%、(D)として第一工業製薬社製DKエステルS−50(商品名)を2.0質量%、殺菌剤としてジクロロイソシアヌル酸ナトリウムを0.1質量%それぞれ計量後混合した後、打錠機にて直径38mm×厚み18mm、重量35gに成形し、ポリプロピレン製袋に封入して炭酸足浴剤の包装体を作成した(サンプルNo.11)。
封入したものを40℃、70%RHの恒温恒湿槽に3ヶ月放置した後、内容物について上記評価法に従い評価した。
遊離二酸化炭素濃度は実施例1と略同等で、実用評価は97%と実施例1よりも若干高めであった。評価者の自由意見には、足浴後のさっぱり感を挙げる者が多かった。
[Example 4]
(A) 29.4% by weight of sodium bicarbonate, (B) 29.4% by weight of succinic acid, (C) 39.1% by weight of anhydrous sodium sulfate, and (D) Daiichi Kogyo Seiyaku Co., Ltd. DK Ester S-50 (trade name) manufactured by 2.0% by mass and sodium dichloroisocyanurate 0.1% by mass as a bactericide were weighed and mixed, and then used in a tableting machine with a diameter of 38 mm, a thickness of 18 mm, and a weight of 35 g. And sealed in a polypropylene bag to produce a carbonated foot bath package (Sample No. 11).
The sealed product was left in a constant temperature and humidity chamber at 40 ° C. and 70% RH for 3 months, and then the contents were evaluated according to the above evaluation method.
The free carbon dioxide concentration was substantially the same as in Example 1, and the practical evaluation was 97%, which was slightly higher than that in Example 1. Many of the evaluators' free opinions expressed a refreshing feeling after taking a foot bath.
本発明は、立ち仕事で足がむくむ、冷え性で夜寝つきが悪い等に悩んでいる人が症状緩和の為に行う足浴の分野で好適に利用できる。 INDUSTRIAL APPLICABILITY The present invention can be suitably used in the field of foot bathing for relief of symptoms by a person who suffers from swelling of feet during standing work, coldness and poor sleep at night.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004008455A JP2005200350A (en) | 2004-01-15 | 2004-01-15 | Carbonated foot bath |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004008455A JP2005200350A (en) | 2004-01-15 | 2004-01-15 | Carbonated foot bath |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2005200350A true JP2005200350A (en) | 2005-07-28 |
Family
ID=34821788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004008455A Pending JP2005200350A (en) | 2004-01-15 | 2004-01-15 | Carbonated foot bath |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005200350A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005314298A (en) * | 2004-04-28 | 2005-11-10 | Kao Corp | Dropsy-ameliorating agent |
| JP2010024184A (en) * | 2008-07-22 | 2010-02-04 | Tsumura Lifescience Co Ltd | Swelling-ameliorating composition and method for ameliorating swelling by utilizing the same |
| JP2012131740A (en) * | 2010-12-22 | 2012-07-12 | Kao Corp | Granular bath agent composition |
| JP2012171875A (en) * | 2011-02-18 | 2012-09-10 | Dr's Choice Co Ltd | Powdery cosmetic for bathing |
| JP2012236825A (en) * | 2011-05-10 | 2012-12-06 | Hot Album Tansansen Tablet Inc | Method for producing tablet |
| JP2013087105A (en) * | 2011-10-21 | 2013-05-13 | Goshu Yakuhin Kk | Bubble-generating bath agent |
| WO2014024299A1 (en) * | 2012-08-10 | 2014-02-13 | クラシエホームプロダクツ株式会社 | Powder bathing cosmetic |
| JP2014234372A (en) * | 2013-06-04 | 2014-12-15 | 花王株式会社 | Foot arch collapse improver |
| JP2016222623A (en) * | 2015-06-02 | 2016-12-28 | レジノカラー工業株式会社 | Surface-treated organic acid composition |
| JP2017031072A (en) * | 2015-07-30 | 2017-02-09 | 花王株式会社 | Solid effervescent bath preparation |
| WO2025126664A1 (en) * | 2023-12-15 | 2025-06-19 | 花王株式会社 | Nonaqueous composition for oral cavity |
-
2004
- 2004-01-15 JP JP2004008455A patent/JP2005200350A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005314298A (en) * | 2004-04-28 | 2005-11-10 | Kao Corp | Dropsy-ameliorating agent |
| JP2010024184A (en) * | 2008-07-22 | 2010-02-04 | Tsumura Lifescience Co Ltd | Swelling-ameliorating composition and method for ameliorating swelling by utilizing the same |
| JP2012131740A (en) * | 2010-12-22 | 2012-07-12 | Kao Corp | Granular bath agent composition |
| JP2012171875A (en) * | 2011-02-18 | 2012-09-10 | Dr's Choice Co Ltd | Powdery cosmetic for bathing |
| JP2012236825A (en) * | 2011-05-10 | 2012-12-06 | Hot Album Tansansen Tablet Inc | Method for producing tablet |
| JP2013087105A (en) * | 2011-10-21 | 2013-05-13 | Goshu Yakuhin Kk | Bubble-generating bath agent |
| WO2014024299A1 (en) * | 2012-08-10 | 2014-02-13 | クラシエホームプロダクツ株式会社 | Powder bathing cosmetic |
| JPWO2014024299A1 (en) * | 2012-08-10 | 2016-07-21 | クラシエホームプロダクツ株式会社 | Powder bath cosmetic |
| JP2014234372A (en) * | 2013-06-04 | 2014-12-15 | 花王株式会社 | Foot arch collapse improver |
| JP2016222623A (en) * | 2015-06-02 | 2016-12-28 | レジノカラー工業株式会社 | Surface-treated organic acid composition |
| JP2017031072A (en) * | 2015-07-30 | 2017-02-09 | 花王株式会社 | Solid effervescent bath preparation |
| CN107735071A (en) * | 2015-07-30 | 2018-02-23 | 花王株式会社 | Solid foaming bath agent |
| CN107735071B (en) * | 2015-07-30 | 2020-11-03 | 花王株式会社 | Solid foaming bath agent |
| WO2025126664A1 (en) * | 2023-12-15 | 2025-06-19 | 花王株式会社 | Nonaqueous composition for oral cavity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5437858A (en) | Oral hygiene agent containing hydrogen peroxide stabilized by colloidal silver | |
| US4557935A (en) | Germicidal composition | |
| US20070172412A1 (en) | Thickened fluid composition comprising chlorine dioxide | |
| JP2005200350A (en) | Carbonated foot bath | |
| TW201021711A (en) | Non-cytotoxic chlorine dioxide fluids | |
| RU2431656C1 (en) | Toilet soap with antimicrobial properties | |
| JPS609009B2 (en) | Foaming bath agent | |
| ES2933031T3 (en) | Tablet containing slow dissolving hypochlorite | |
| RU2412688C2 (en) | Stabilised oxygen-release composition | |
| KR102397070B1 (en) | Formulations of calcium and phosphate for oral inflammation | |
| JP2003079530A (en) | Wet tissue | |
| JPS623803B2 (en) | ||
| JP2558188B2 (en) | Bath agent composition | |
| JP3522380B2 (en) | Bath composition | |
| JP2010037264A (en) | Effervescent bath agent | |
| EP1926472B1 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
| JP7382766B2 (en) | Foaming solid bath additive | |
| JP6829620B2 (en) | Solid bath salt | |
| JPS6021967B2 (en) | A disinfectant that is fast-acting and long-lasting. | |
| JPH03112922A (en) | Foamable bathing agent for inhibiting floating of fumaric acid | |
| JP2001278764A (en) | Transparent solid axillary odor inhibitor and manufacturing method | |
| JPS60109525A (en) | Stabilized chlorine dioxide agent used for additive in skin remedy | |
| JP2019193606A (en) | Stabilized vitamin c-combined pharmaceutical | |
| JP2003095916A (en) | Tablet for sparkling bath | |
| WO2014141938A1 (en) | Denture detergent |